Adefovir Dipivoxil Market Overview, Growth, and Oppotunities by 2031
Adefovir is prescribed drug used for the treatment of hepatitis B infection. The drug is also called as bis-POM PMEA and is orally administered for various infectious diseases, especially hepatitis B. The medication is acyclic nucleotide analog reverse transcriptase inhibitor (ntRTI) and plays vital role in lowering the growth of virus.
Read More: - [a]https%3A%2F%2Fwww.theinsightpartners.com%2Freports%2Fadefovir-dipivoxil-market[/a]
